Woodline Partners »

Tellurian shares owned by Woodline Partners

Quarter-by-quarter ownership of Tellurian (TELL) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Tellurian

Tip: Access up to 7 years of quarterly data

All positions including Tellurian held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tellurian by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.8M 6.0M 0.97

More positions owned by Woodline Partners

Meta Platforms Cl A (META)
Gilead Sciences (GILD)
Abbvie (ABBV)
Revolution Medicines (RVMD)
Vaxcyte (PCVX)
Asml Holding N V N Y Registry Shs (ASML)
Nuvalent Inc-a (NUVL)
Permian Resources Corp Class A Com (PR)
Encana Corporation (OVV)
Keysight Technologies (KEYS)
Danaher Corporation (DHR)
Aon Shs Cl A (AON)
Stmicroelectronics N V Ny Registry (STM)
Regeneron Pharmaceuticals (REGN)
EQT Corporation (EQT)

View all positions for Woodline Partners

Top funds holding Tellurian

Vanguard Group
Magnetar Financial
Paulson & Co
CNH Partners
BlackRock
PSquared Asset Management
BlackRock
LMR Partners
State Street Corporation
Barclays
Geode Capital Management
Melqart Asset Management
Woodline Partners
Charles Schwab Investment Management
Alpine Associates Management

View all funds holding Tellurian